This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting neurological disorders, particularly those involving dopamine regulation. Its unique structure allows it to act as a precursor in the creation of compounds that interact with specific receptors in the brain, making it valuable for research and production of treatments for conditions such as Parkinson's disease and schizophrenia. Additionally, its application extends to the study of enzyme inhibition, where it is used to explore potential therapeutic agents for various metabolic and psychiatric conditions.